Cognitive-Behavioral Therapy for Anorexia

N/A

Waitlist Available

Research Sponsored by Massachusetts General Hospital

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Age > 18

Be older than 18 years old

Must not have

BMI < 15 or > 18.5, obtained via patient medical chart or from study 2023P000469 or 2018P002915.

Symptoms that are not appropriate for outpatient level of care and therefore require a higher level of care (i.e. BMI <15 or purging more than 3x/week)

Timeline

Screening 3 weeks

Treatment Varies

Follow Up change from week one of study treatment to post-treatment following final session, an average of 25 weeks after week one (measured at weeks one, six, and twenty), and to the six-month follow-up session, up to 11 months after week one.

Awards & highlights

No Placebo-Only Group

Summary

This trial will test a new therapy for adults with anorexia. Researchers expect participants to gain weight, improve their eating disorder symptoms, and maintain these improvements for at least 6 months after treatment.

Who is the study for?

Adults aged 18 and over with anorexia nervosa can join this study. The trial is designed to help them gain weight and reduce eating disorder behaviors. Participants must be able to attend twenty therapy sessions.

What is being tested?

The trial tests a new twenty-session cognitive-behavioral therapy (CBT-20-AN) specifically for adults with anorexia nervosa, aiming to see if it helps patients gain weight and improve their relationship with food.

What are the potential side effects?

Since the intervention involves therapy sessions, there are no direct medical side effects like you'd expect from medication. However, participants may experience emotional discomfort or distress as they confront their eating disorder.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Select...

I am older than 18 years.

Exclusion Criteria

You may be eligible for the trial if you check “No” for criteria below:

Select...

My BMI is either below 15 or above 18.5.

Select...

My symptoms are severe, needing more than regular outpatient care.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ change from week one of study treatment to post-treatment following final session, an average of 25 weeks after week one (measured at weeks one, six, and twenty), and to one, three, and six-month follow-up sessions, up to 11 months after week one.

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~change from week one of study treatment to post-treatment following final session, an average of 25 weeks after week one (measured at weeks one, six, and twenty), and to one, three, and six-month follow-up sessions, up to 11 months after week one.

This trial's timeline: 3 weeks for screening, Varies for treatment, and change from week one of study treatment to post-treatment following final session, an average of 25 weeks after week one (measured at weeks one, six, and twenty), and to one, three, and six-month follow-up sessions, up to 11 months after week one. for reporting.